Drug developers have been acquiring complimentary programs to reduce execution risk and maintain investor interest.

Fin Resources executes agreement to acquire fully permitted, drill-ready Cabin Lake gold project in Tier-1 Northwest ...

Amazon’s nuclear plan for its AI operations has fuelled debate about Australia’s energy future, with tech leaders warning we ...

Join Matt Preston as he explores Karijini, a largely unknown national park on the eastern seaboard that rivals Australia's ...

Ark Mines (ASX:AHK) is close to completing groundwork at the Sandy Mitchell project as environmental baseline studies ...

CSL analysts reckon the healthcare giant is undervalued after Tuesday's market hiding, but remain bearish about a near-term ...

The ASX was cruising early before a hotter-than-expected CPI smacked the rally. Meanwhile CSL was bruised again, but Boss ...

The ASX 200 was looking a little unsteady this morning, overloaded by a barrage of quarterlies as reporting season kicks off ...

Quarterly season is almost done, and David Franklyn joins to give his best and worst September gold performers, plus a ...

Macquarie Bank’s provision of funding for QPM Energy’s Issac Power Station is a sign that east coast plays could have more ...

Wellness has gone to a trillion-dollar lifestyle, and EZZ Life Science is diving straight into America’s booming self-care ...

In this latest episode of Stockhead’s Who’s Who on the ASX, host Tylah Tully spotlights Codeifai (ASX:CDE). Codeifai offers ...